For US health care facilities, participation in the World Health Organization global campaign to improve hand hygiene practices is associated with improved hand hygiene, according to a study published in the March issue of the American Journal of Infection Control.
Human subjects protections policies do not provide regulatory coverage for all clinical trials, while up to about a quarter of trials are considered overlap trials, according to a research letter published in the March 5 issue of the Journal of the American Medical Association.
For patients with advanced melanoma, nivolumab may improve overall survival and has an acceptable long-term safety profile, according to a study published online March 3 in the Journal of Clinical Oncology.
Women are still underrepresented in medical science and research, and sex differences are often ignored, according to a report published March 3 by the Brigham and Women's Hospital.
There will be no more delays to the Oct. 1, 2014, deadline for implementation of the International Classification of Diseases, 10th Revision, according to an article published Feb. 27 in Medical Economics.
Indoor tanning is common among high school students and is linked to engaging in other risky behaviors, according to a study published online Feb. 26 in JAMA Dermatology.
Successful applications of nanotechnology in the field of immunology will enable new generations of vaccines, adjuvants, and immunomodulatory drugs that aim to improve clinical outcomes in response in a range of infectious and non-infectious diseases.
Implementing an electronic health record system takes excessive physician and staff time and disrupts practice, according to survey results published Feb. 24 in Medical Economics.
Significant weight loss can be a monumental step in a person’s life, but one setback many patients face after massive weight loss is excess, sagging skin that will not vanish without surgical intervention.
Due to its ambiguous etiology, the low cost-to-benefit ratio associated with many laboratory tests used in assessment and diagnosis, and the low-to-moderate strength of evidence supporting many pharmacologic approaches to treatment, chronic urticaria can be one of the most difficult inflammatory skin conditions for clinicians to manage.